Fig. 3From: Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysisBubble charts of incidence density according to preexisting cirrhosis proportion. Trend lines fitted linearly represent the predicted HCC incidence density according to different treatments. ETV, Entecavir; TDF, Tenofovir disoproxil fumarate; Other NAs, Nucleos(t)ide Analogues other than ETV and TDF (including Lamivudine, Telbivudine and Adefovir). The bubble size represents the sample size for each studyBack to article page